StonvexLoading…
StonvexStonvexStonvexCore line items from IPGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $265.50M | $1.00B | $729.31M | $478.51M |
Operating Income | $-7.74M | $13.10M | $9.79M | $1.93M |
Net Income | $1.58M | $31.10M | $17.83M | $10.36M |
EPS (Diluted) | $0.04 | $0.73 | $0.42 | $0.24 |
Total Assets | $2.42B | $2.42B | $2.38B | $2.38B |
Total Liabilities | $305.85M | $296.15M | $276.15M | $274.90M |
Cash & Equivalents | $480.76M | $403.79M | $346.03M | $359.18M |
Free Cash Flow OCF − CapEx | $-21.77M | $-3.45M | $-14.37M | $-28.95M |
Shares Outstanding | 42.44M | 42.13M | 42.12M | 42.33M |